Send me a link:

*Text messaging rates may apply.

 Dow Up 0.08% Nasdaq Down 0.08%

Zogenix, Inc. (ZGNX)

-NasdaqGM
1.50 Down 0.07(4.15%) 1:32PM EDT - Nasdaq Real Time Price
Prev Close:1.57
Open:1.56
Bid:1.49 x 11900
Ask:1.50 x 4100
1y Target Est:4.18
Beta:1.89
Next Earnings Date: 5-Aug-14ZGNX Earnings announcement
Day's Range:1.46 - 1.58
52wk Range:1.46 - 5.19
Volume:1,277,390
Avg Vol (3m):2,405,840
Market Cap:209.31M
P/E (ttm):N/A
EPS (ttm):-0.75
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZGNXDown 4.15%209.31M
AZNDown 0.78%93.19B
GSKDown 0.88%115.70B
PFEDown 0.55%191.52B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.64
Quarterly EPS Est (Jun-14) :-0.16
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):-0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback